Cary Street Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Sell
44,828
-3,095
-6% -$282K 0.09% 230
2026
Q1
$4.92M Sell
47,923
-1,747
-4% -$197K 0.12% 179
2025
Q4
$6.22M Sell
49,670
-4,602
-8% -$586K 0.15% 149
2025
Q3
$7.27M Sell
54,272
-423
-0.8% -$55.5K 0.19% 128
2025
Q2
$7.44M Sell
54,695
-1,669
-3% -$220K 0.21% 119
2025
Q1
$7.48M Buy
56,364
+2,569
+5% +$327K 0.24% 100
2024
Q4
$6.08M Buy
+53,795
New +$6.22M 0.2% 116

Other funds holding ABT

Cary Street Partners's ABT Position: Q2 2026 in Review

Cary Street Partners reduced its Abbott (ABT) stake by 6.5% in Q2 2026, selling an estimated $282K and leaving 44,828 shares worth $4.07M. The position accounts for 0.09% of the portfolio, ranked #230.

Cary Street Partners first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.48M in Q1 2025. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Cary Street Partners held 44,828 shares of Abbott worth $4.07M as of Q2 2026.
  • Cary Street Partners sold 3,095 Abbott shares in Q2 2026, an estimated $282K.
  • Abbott made up 0.09% of Cary Street Partners's portfolio in Q2 2026, its #230 holding.
  • Cary Street Partners first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Abbott position peaked at $7.48M in Q1 2025.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.